Personalis, Inc. Earnings Per Share (Diluted)
Personalis, Inc. (PSNL) reported Earnings Per Share (Diluted) of -$0.30 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-04
- Personalis, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.30.
- Personalis, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was -$0.29.
- Personalis, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was -$0.26.
- Personalis, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was -$0.24.
- Personalis, Inc. earnings per share, diluted for fiscal 2025 was -$0.91.
- Personalis, Inc. earnings per share, diluted for fiscal 2024 was -$1.37.
- Personalis, Inc. earnings per share, diluted for fiscal 2023 was -$2.25.
- Personalis, Inc. earnings per share, diluted for fiscal 2022 was -$2.48.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.30 10-Q · filed 2026-08-04 | -$0.59 10-Q · filed 2026-08-04 | -$0.85 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$1.10 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2026-03-31 | -$0.29 10-Q · filed 2026-05-07 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.79 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$1.02 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-12-31 | -$0.26 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.50 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.73 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.91 10-K · filed 2026-02-26 |
| 2025-09-30 | -$0.24 10-Q · filed 2025-11-04 | -$0.47 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.65 10-Q · filed 2025-11-04 | -$0.88 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-06-30 | -$0.23 10-Q · filed 2026-08-04 | -$0.41 10-Q · filed 2026-08-04 | -$0.63 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$1.18 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-03-31 | -$0.18 10-Q · filed 2026-05-07 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.97 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$1.23 derived: net income ÷ weighted average shares · filed 2026-05-07 |
| 2024-12-31 | -$0.23 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$0.83 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.10 derived: net income ÷ weighted average shares · filed 2026-02-26 | -$1.37 10-K · filed 2026-02-26 |
| 2024-09-30 | -$0.64 10-Q · filed 2025-11-04 | -$0.91 derived: net income ÷ weighted average shares · filed 2025-11-04 | -$1.19 10-Q · filed 2025-11-04 | -$1.71 derived: net income ÷ weighted average shares · filed 2025-11-04 |
| 2024-06-30 | -$0.24 10-Q · filed 2025-08-05 | -$0.50 10-Q · filed 2025-08-05 | -$1.03 derived: net income ÷ weighted average shares · filed 2025-08-05 | -$1.62 derived: net income ÷ weighted average shares · filed 2025-08-05 |
| 2024-03-31 | -$0.26 10-Q · filed 2025-05-06 | -$0.79 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$1.38 derived: net income ÷ weighted average shares · filed 2025-05-06 | -$1.88 derived: net income ÷ weighted average shares · filed 2025-05-06 |
| 2023-12-31 | -$0.54 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$1.13 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$1.64 derived: net income ÷ weighted average shares · filed 2025-02-27 | -$2.25 10-K · filed 2025-02-27 |
| 2023-09-30 | -$0.60 10-Q · filed 2024-11-06 | -$1.10 derived: net income ÷ weighted average shares · filed 2024-11-06 | -$1.71 10-Q · filed 2024-11-06 | -$2.38 derived: net income ÷ weighted average shares · filed 2024-11-06 |
| 2023-06-30 | -$0.50 10-Q · filed 2024-08-07 | -$1.11 10-Q · filed 2024-08-07 | -$1.78 derived: net income ÷ weighted average shares · filed 2024-08-07 | -$2.36 derived: net income ÷ weighted average shares · filed 2024-08-07 |
| 2023-03-31 | -$0.61 10-Q · filed 2024-05-08 | -$1.28 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$1.86 derived: net income ÷ weighted average shares · filed 2024-05-08 | -$2.47 derived: net income ÷ weighted average shares · filed 2024-05-08 |
| 2022-12-31 | -$0.67 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$1.25 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$1.85 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$2.48 10-K · filed 2024-02-28 |
| 2022-09-30 | -$0.58 10-Q · filed 2023-11-07 | -$1.18 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.81 10-Q · filed 2023-11-07 | -$2.26 derived: net income ÷ weighted average shares · filed 2024-02-28 |
| 2022-06-30 | -$0.60 10-Q · filed 2023-08-08 | -$1.23 10-Q · filed 2023-08-08 | -$1.68 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$2.08 derived: net income ÷ weighted average shares · filed 2024-02-28 |
| 2022-03-31 | -$0.63 10-Q · filed 2023-05-03 | -$1.08 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$1.48 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$1.82 derived: net income ÷ weighted average shares · filed 2024-02-28 |
| 2021-12-31 | -$0.45 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$0.85 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$1.19 derived: net income ÷ weighted average shares · filed 2024-02-28 | -$1.49 10-K · filed 2024-02-28 |
| 2021-09-30 | -$0.40 10-Q · filed 2022-11-02 | -$0.74 derived: net income ÷ weighted average shares · filed 2022-11-02 | -$1.03 10-Q · filed 2022-11-02 | |
| 2021-06-30 | -$0.34 10-Q · filed 2022-08-03 | -$0.63 10-Q · filed 2022-08-03 | ||
| 2020-12-31 | -$1.20 10-K · filed 2023-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |